-
2
-
-
4344607526
-
Endocrine regulation of energy metabolism: Review of pathobiochemical and clinical aspects of leptin, ghrelin, adiponectin, and resistin
-
U. Meier, and A.M. Gressner Endocrine regulation of energy metabolism: review of pathobiochemical and clinical aspects of leptin, ghrelin, adiponectin, and resistin Clin Chem 50 2004 1511 1525
-
(2004)
Clin Chem
, vol.50
, pp. 1511-1525
-
-
Meier, U.1
Gressner, A.M.2
-
3
-
-
0028787490
-
A novel serum protein similar to C1q, produced exclusively in adipocytes
-
P.E. Scherer, S. Williams, and M. Fogliano A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 1995 26746 26749
-
(1995)
J Biol Chem
, vol.270
, pp. 26746-26749
-
-
Scherer, P.E.1
Williams, S.2
Fogliano, M.3
-
4
-
-
0036750241
-
Adiponectin - Its role in metabolism and beyond
-
N. Stefan, and M. Stumvoll Adiponectin - its role in metabolism and beyond Horm Metab Res 34 2002 469 474
-
(2002)
Horm Metab Res
, vol.34
, pp. 469-474
-
-
Stefan, N.1
Stumvoll, M.2
-
5
-
-
0036511213
-
ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism
-
A.H. Berg, T.P. Combs, and P.E. Scherer ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism Trends Endocrinol Metab 13 2002 84 89
-
(2002)
Trends Endocrinol Metab
, vol.13
, pp. 84-89
-
-
Berg, A.H.1
Combs, T.P.2
Scherer, P.E.3
-
6
-
-
81155137747
-
Effects of leptin and adiponectin on pancreatic β-cell function
-
Y.H. Lee, F. Magkos, and C.S. Mantzoros Effects of leptin and adiponectin on pancreatic β-cell function Metabolism 60 2011 1664 1672
-
(2011)
Metabolism
, vol.60
, pp. 1664-1672
-
-
Lee, Y.H.1
Magkos, F.2
Mantzoros, C.S.3
-
7
-
-
80054974212
-
Plasma adiponectin - An independent indicator of liver fat accumulation
-
P. Pisto, O. Ukkola, and M. Santaniemi Plasma adiponectin - an independent indicator of liver fat accumulation Metabolism 60 2011 1515 1520
-
(2011)
Metabolism
, vol.60
, pp. 1515-1520
-
-
Pisto, P.1
Ukkola, O.2
Santaniemi, M.3
-
8
-
-
79951810722
-
Serum total adiponectin in nonalcoholic fatty liver disease: A systematic review and meta-analysis
-
S.A. Polyzos, K.A. Toulis, D.G. Goulis, C. Zavos, and J. Kountouras Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis Metabolism 60 2011 313 326
-
(2011)
Metabolism
, vol.60
, pp. 313-326
-
-
Polyzos, S.A.1
Toulis, K.A.2
Goulis, D.G.3
Zavos, C.4
Kountouras, J.5
-
9
-
-
33750515920
-
Role of adipokines in the control of energy metabolism: Focus on adiponectin
-
M. Lafontan, and N. Viguerie Role of adipokines in the control of energy metabolism: focus on adiponectin Curr Opin Pharmacol 6 2006 580 585
-
(2006)
Curr Opin Pharmacol
, vol.6
, pp. 580-585
-
-
Lafontan, M.1
Viguerie, N.2
-
10
-
-
84870401115
-
Protective role of adiponectin in cardiovascular disease
-
R. Shibata, T. Murohara, and N. Ouchi Protective role of adiponectin in cardiovascular disease Curr Med Chem 19 2012 5459 5466
-
(2012)
Curr Med Chem
, vol.19
, pp. 5459-5466
-
-
Shibata, R.1
Murohara, T.2
Ouchi, N.3
-
11
-
-
84858199982
-
Adiponectin and cardiovascular disease: Mechanisms and new therapeutic approaches
-
G. Siasos, D. Tousoulis, and C. Kollia Adiponectin and cardiovascular disease: mechanisms and new therapeutic approaches Curr Med Chem 19 2012 1193 1209
-
(2012)
Curr Med Chem
, vol.19
, pp. 1193-1209
-
-
Siasos, G.1
Tousoulis, D.2
Kollia, C.3
-
12
-
-
81855177709
-
Adiponectin and cardiovascular health: An update
-
X. Hui, K.S. Lam, and P.M. Vanhoutte Adiponectin and cardiovascular health: an update Br J Pharmacol 165 2012 574 590
-
(2012)
Br J Pharmacol
, vol.165
, pp. 574-590
-
-
Hui, X.1
Lam, K.S.2
Vanhoutte, P.M.3
-
13
-
-
84869487793
-
Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease
-
Q. Li, Y. Lu, and L. Sun Plasma adiponectin levels in relation to prognosis in patients with angiographic coronary artery disease Metabolism 61 2012 1803 1808
-
(2012)
Metabolism
, vol.61
, pp. 1803-1808
-
-
Li, Q.1
Lu, Y.2
Sun, L.3
-
14
-
-
78751646231
-
Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure
-
D. Giannessi, C. Caselli, and S. Del Ry Adiponectin is associated with abnormal lipid profile and coronary microvascular dysfunction in patients with dilated cardiomyopathy without overt heart failure Metabolism 60 2011 227 233
-
(2011)
Metabolism
, vol.60
, pp. 227-233
-
-
Giannessi, D.1
Caselli, C.2
Del Ry, S.3
-
15
-
-
84866002800
-
Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism
-
Q. Liu, B. Yuan, and K.A. Lo Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism Proc Natl Acad Sci U S A 109 2012 14568 14573
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 14568-14573
-
-
Liu, Q.1
Yuan, B.2
Lo, K.A.3
-
16
-
-
34047265043
-
Role of adiponectin in the regulation of carbohydrate and lipid metabolism
-
J. Karbowska, and Z. Kochan Role of adiponectin in the regulation of carbohydrate and lipid metabolism J Physiol Pharmacol 57 2006 S103 S113
-
(2006)
J Physiol Pharmacol
, vol.57
-
-
Karbowska, J.1
Kochan, Z.2
-
17
-
-
84866107607
-
Insulin-sensitizing properties of adiponectin
-
J.M. Tishinsky, L.E. Robinson, and D.J. Dyck Insulin-sensitizing properties of adiponectin Biochimie 94 2012 2131 2136
-
(2012)
Biochimie
, vol.94
, pp. 2131-2136
-
-
Tishinsky, J.M.1
Robinson, L.E.2
Dyck, D.J.3
-
19
-
-
34548406102
-
Adiponectin, obesity and atherosclerosis
-
C.J. Behre Adiponectin, obesity and atherosclerosis Scand J Clin Lab Invest 67 2007 449 458
-
(2007)
Scand J Clin Lab Invest
, vol.67
, pp. 449-458
-
-
Behre, C.J.1
-
20
-
-
27544513825
-
Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance
-
M. Haluzik Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance Curr Opin Investig Drugs 6 2005 988 993
-
(2005)
Curr Opin Investig Drugs
, vol.6
, pp. 988-993
-
-
Haluzik, M.1
-
21
-
-
84870735957
-
Effects of adiponectin on oxidative stress and apoptosis in human cardiac myocytes cultured with high glucose
-
X. Li, M.R. Li, and Z.X. Guo Effects of adiponectin on oxidative stress and apoptosis in human cardiac myocytes cultured with high glucose Chin Med J 125 2012 4209 4213
-
(2012)
Chin Med J
, vol.125
, pp. 4209-4213
-
-
Li, X.1
Li, M.R.2
Guo, Z.X.3
-
22
-
-
84866054662
-
Adiponectin: Anti-inflammatory and cardioprotective effects
-
M.T. Villarreal-Molina, and B. Antuna-Puente Adiponectin: anti-inflammatory and cardioprotective effects Biochimie 94 2012 2143 2149
-
(2012)
Biochimie
, vol.94
, pp. 2143-2149
-
-
Villarreal-Molina, M.T.1
Antuna-Puente, B.2
-
23
-
-
33947627537
-
Adiponectin as an anti-inflammatory factor
-
N. Ouchi, and K. Walsh Adiponectin as an anti-inflammatory factor Clin Chim Acta 380 2007 24 30
-
(2007)
Clin Chim Acta
, vol.380
, pp. 24-30
-
-
Ouchi, N.1
Walsh, K.2
-
25
-
-
0034096988
-
Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
-
K. Hotta, T. Funahashi, and Y. Arita Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol 20 2000 1595 1599
-
(2000)
Arterioscler Thromb Vasc Biol
, vol.20
, pp. 1595-1599
-
-
Hotta, K.1
Funahashi, T.2
Arita, Y.3
-
26
-
-
11144346107
-
Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesionmolecules in subjects with metabolic syndrome
-
U. Salmenniemi, E. Ruotsalainen, and J. Pihlajamaki Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesionmolecules in subjects with metabolic syndrome Circulation 110 2004 3842 3848
-
(2004)
Circulation
, vol.110
, pp. 3842-3848
-
-
Salmenniemi, U.1
Ruotsalainen, E.2
Pihlajamaki, J.3
-
27
-
-
48649107955
-
Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in non-diabetic coronary arteries
-
S.P. Marso, S.K. Mehta, and A. Frutkin Low adiponectin levels are associated with atherogenic dyslipidemia and lipid-rich plaque in non-diabetic coronary arteries Diabetes Care 31 2008 989 994
-
(2008)
Diabetes Care
, vol.31
, pp. 989-994
-
-
Marso, S.P.1
Mehta, S.K.2
Frutkin, A.3
-
28
-
-
42249093693
-
The association between plasma adiponectin level and hypertension
-
A. Shankar, S. Marshall, and J. Li The association between plasma adiponectin level and hypertension Acta Cardiol 63 2008 160 165
-
(2008)
Acta Cardiol
, vol.63
, pp. 160-165
-
-
Shankar, A.1
Marshall, S.2
Li, J.3
-
29
-
-
0037231459
-
Osaka CAD Study Group: Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men
-
M. Kumada, S. Kihara, and S. Sumitsuji Osaka CAD Study Group: coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men Arterioscler Thromb Vasc Biol 23 2003 85 89
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 85-89
-
-
Kumada, M.1
Kihara, S.2
Sumitsuji, S.3
-
30
-
-
84874824533
-
Serum levels of adiponectin and ghrelin in patients with acute myocardial infarction
-
E.O. Hamed, N.A. Zaky, and A.K. Norel Din Serum levels of adiponectin and ghrelin in patients with acute myocardial infarction Life Sci J 9 2012 523 526
-
(2012)
Life Sci J
, vol.9
, pp. 523-526
-
-
Hamed, E.O.1
Zaky, N.A.2
Norel Din, A.K.3
-
31
-
-
84870406340
-
Therapeutic perspectives for adiponectin: An update
-
F.Y.L. Li, K.S.L. Lam, and A. Xu Therapeutic perspectives for adiponectin: an update Curr Med Chem 19 2012 5513 5523
-
(2012)
Curr Med Chem
, vol.19
, pp. 5513-5523
-
-
Li, F.Y.L.1
Lam, K.S.L.2
Xu, A.3
-
33
-
-
26244432388
-
Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
-
C. Baigent, A. Keech, and P.M. Kearney Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
-
(2005)
Lancet
, vol.366
, pp. 1267-1278
-
-
Baigent, C.1
Keech, A.2
Kearney, P.M.3
-
34
-
-
77952708442
-
Effects of fibrates on cardiovascular outcomes: A systematic review and meta-analysis
-
M. Jun, C. Foote, and J. Lv Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis Lancet 375 2010 1875 1884
-
(2010)
Lancet
, vol.375
, pp. 1875-1884
-
-
Jun, M.1
Foote, C.2
Lv, J.3
-
35
-
-
70349342714
-
Effect of fibrates on lipid profiles and cardiovascular outcomes: A systematic review
-
S. Abourbih, K.B. Filion, and L. Joseph Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review Am J Med 122 2009 962
-
(2009)
Am J Med
, vol.122
, pp. 962
-
-
Abourbih, S.1
Filion, K.B.2
Joseph, L.3
-
36
-
-
28044452217
-
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial
-
A. Keech, R.J. Simes, and P. Barter Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial Lancet 366 2005 1849 1861
-
(2005)
Lancet
, vol.366
, pp. 1849-1861
-
-
Keech, A.1
Simes, R.J.2
Barter, P.3
-
37
-
-
77951704587
-
Effects of combination lipid therapy in type 2 diabetes mellitus
-
ACCORD Study Group
-
ACCORD Study Group H.N. Ginsberg, M.B. Elam, and L.C. Lovato Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med 362 2010 1563 1574
-
(2010)
N Engl J Med
, vol.362
, pp. 1563-1574
-
-
Ginsberg, H.N.1
Elam, M.B.2
Lovato, L.C.3
-
38
-
-
0037319739
-
Statin effects beyond lipid lowering - Are they clinically relevant?
-
P.O. Bonetti, L.O. Lerman, and C. Napoli Statin effects beyond lipid lowering - are they clinically relevant? Eur Heart J 24 2003 225 248
-
(2003)
Eur Heart J
, vol.24
, pp. 225-248
-
-
Bonetti, P.O.1
Lerman, L.O.2
Napoli, C.3
-
41
-
-
79956315187
-
Pleiotropic effects of statins: Evidence for benefits beyond LDL-cholesterol lowering
-
M. Marzilli Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering Am J Cardiovasc Drugs 10 2010 S3 S9
-
(2010)
Am J Cardiovasc Drugs
, vol.10
-
-
Marzilli, M.1
-
43
-
-
84881642500
-
Fibrate therapy and circulating adiponectin concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials
-
A. Sahebkar, G.F. Watts, and D. Perrea Fibrate therapy and circulating adiponectin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials Atherosclerosis 230 2013 110 120
-
(2013)
Atherosclerosis
, vol.230
, pp. 110-120
-
-
Sahebkar, A.1
Watts, G.F.2
Perrea, D.3
-
44
-
-
18944381282
-
Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia
-
K.K. Koh, M.J. Quon, and S.H. Han Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia J Am Coll Cardiol 45 2005 1649 1653
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1649-1653
-
-
Koh, K.K.1
Quon, M.J.2
Han, S.H.3
-
45
-
-
34249731922
-
Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia
-
C. Otto, B. Otto, and R.J. Frost Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia Acta Diabetol 44 2007 65 68
-
(2007)
Acta Diabetol
, vol.44
, pp. 65-68
-
-
Otto, C.1
Otto, B.2
Frost, R.J.3
-
46
-
-
34447322025
-
Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia
-
T. Nakamura, Y. Kodama, and H. Takano Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia Atherosclerosis 193 2007 449 451
-
(2007)
Atherosclerosis
, vol.193
, pp. 449-451
-
-
Nakamura, T.1
Kodama, Y.2
Takano, H.3
-
47
-
-
70350575193
-
Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment
-
M. Arca, V.M. Cambuli, and A. Montali Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment Nutr Metab Cardiovasc Dis 19 2009 660 666
-
(2009)
Nutr Metab Cardiovasc Dis
, vol.19
, pp. 660-666
-
-
Arca, M.1
Cambuli, V.M.2
Montali, A.3
-
48
-
-
79958821408
-
Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087
-
C.J. Fichtenbaum, T.M. Yeh, and S.R. Evans Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087 J Clin Lipidol 4 2010 279 287
-
(2010)
J Clin Lipidol
, vol.4
, pp. 279-287
-
-
Fichtenbaum, C.J.1
Yeh, T.M.2
Evans, S.R.3
-
49
-
-
84867908899
-
Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose
-
L. Buldak, A. Dulawa-Buldak, and K. Labuzek Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose Int J Clin Pharmacol Ther 50 2012 805 813
-
(2012)
Int J Clin Pharmacol Ther
, vol.50
, pp. 805-813
-
-
Buldak, L.1
Dulawa-Buldak, A.2
Labuzek, K.3
-
50
-
-
69449100622
-
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
-
D. Moher, A. Liberati, and J. Tetzlaff Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 339 2009 b2535
-
(2009)
BMJ
, vol.339
, pp. 2535
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
-
52
-
-
21544449115
-
Estimating the mean and variance from the median, range, and the size of a sample
-
S. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
-
(2005)
BMC Med Res Methodol
, vol.5
, pp. 13
-
-
Hozo, S.1
Djulbegovic, B.2
Hozo, I.3
-
53
-
-
84876135427
-
Does PPARγ2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis
-
A. Sahebkar Does PPARγ2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis DNA Cell Biol 32 2013 188 198
-
(2013)
DNA Cell Biol
, vol.32
, pp. 188-198
-
-
Sahebkar, A.1
-
54
-
-
0033934949
-
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
-
S. Duval, and R. Tweedie Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis Biometrics 56 2000 455 463
-
(2000)
Biometrics
, vol.56
, pp. 455-463
-
-
Duval, S.1
Tweedie, R.2
-
56
-
-
78651085122
-
Do statins beneficially or adversely affect glucose homeostasis?
-
M.S. Kostapanos, G.L. Liamis, and H.J. Milionis Do statins beneficially or adversely affect glucose homeostasis? Curr Vasc Pharmacol 8 2010 612 631
-
(2010)
Curr Vasc Pharmacol
, vol.8
, pp. 612-631
-
-
Kostapanos, M.S.1
Liamis, G.L.2
Milionis, H.J.3
-
57
-
-
67650702822
-
Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients
-
R. Sukhija, S. Prayaga, and M. Marashdeh Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients J Invest Med 57 2009 495 499
-
(2009)
J Invest Med
, vol.57
, pp. 495-499
-
-
Sukhija, R.1
Prayaga, S.2
Marashdeh, M.3
-
58
-
-
84869858921
-
Comparative study of the improvement effect of switching from fenofibrate to bezafibrate on lipid and glucose metabolism - Differences in effects between bezafibrate and fenofibrate in clinical practice
-
T. Goto, S. Yoshioka, and A. Suzuki Comparative study of the improvement effect of switching from fenofibrate to bezafibrate on lipid and glucose metabolism - differences in effects between bezafibrate and fenofibrate in clinical practice Ther Res 33 2012 1561 1568
-
(2012)
Ther Res
, vol.33
, pp. 1561-1568
-
-
Goto, T.1
Yoshioka, S.2
Suzuki, A.3
-
59
-
-
48749131386
-
Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients
-
H. Ando, K. Sugimoto, and H. Yanagihara Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients Clin Exp Pharmacol Physiol 35 2008 1012 1017
-
(2008)
Clin Exp Pharmacol Physiol
, vol.35
, pp. 1012-1017
-
-
Ando, H.1
Sugimoto, K.2
Yanagihara, H.3
-
60
-
-
34547887274
-
Efficacy of atorvastatin therapy in ischaemic heart disease - Effects on oxidized low-density lipoprotein and adiponectin
-
K. Miyagishima, S. Hiramitsu, and S. Kato Efficacy of atorvastatin therapy in ischaemic heart disease - effects on oxidized low-density lipoprotein and adiponectin J Int Med Res 35 2007 534 539
-
(2007)
J Int Med Res
, vol.35
, pp. 534-539
-
-
Miyagishima, K.1
Hiramitsu, S.2
Kato, S.3
-
61
-
-
43749111768
-
Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk
-
L.M. Blanco-Colio, J.L. Martin-Ventura, and C. Gomez-Guerrero Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk Eur J Pharmacol 586 2008 259 265
-
(2008)
Eur J Pharmacol
, vol.586
, pp. 259-265
-
-
Blanco-Colio, L.M.1
Martin-Ventura, J.L.2
Gomez-Guerrero, C.3
-
62
-
-
33748590264
-
The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: A pilot study
-
K. Sakamoto, T. Sakamoto, and H. Ogawa The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: a pilot study Clin Ther 28 2006 1012 1021
-
(2006)
Clin Ther
, vol.28
, pp. 1012-1021
-
-
Sakamoto, K.1
Sakamoto, T.2
Ogawa, H.3
-
63
-
-
34548500220
-
Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease
-
S. Sugiyama, H. Fukushima, and K. Kugiyama Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease Atherosclerosis 194 2007 e43 e51
-
(2007)
Atherosclerosis
, vol.194
-
-
Sugiyama, S.1
Fukushima, H.2
Kugiyama, K.3
-
64
-
-
79960988152
-
Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism
-
B. Cariou, Y. Zaïr, and B. Staels Effects of the new dual PPAR α/δ agonist GFT505 on lipid and glucose homeostasis in abdominally obese patients with combined dyslipidemia or impaired glucose metabolism Diabetes Care 34 2011 2008 2014
-
(2011)
Diabetes Care
, vol.34
, pp. 2008-2014
-
-
Cariou, B.1
Zaïr, Y.2
Staels, B.3
-
65
-
-
60849116123
-
Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients
-
R.S. Rosenson Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients Obesity (Silver Spring) 17 2009 504 509
-
(2009)
Obesity (Silver Spring)
, vol.17
, pp. 504-509
-
-
Rosenson, R.S.1
-
66
-
-
76149092815
-
Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome
-
R. Belfort, R. Berria, and J. Cornell Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome J Clin Endocrinol Metab 95 2010 829 836
-
(2010)
J Clin Endocrinol Metab
, vol.95
, pp. 829-836
-
-
Belfort, R.1
Berria, R.2
Cornell, J.3
-
67
-
-
79960239872
-
Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: Results from a crossover study
-
T. Noguchi, J. Kobayashi, and K. Yagi Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: results from a crossover study Atherosclerosis 217 2011 165 170
-
(2011)
Atherosclerosis
, vol.217
, pp. 165-170
-
-
Noguchi, T.1
Kobayashi, J.2
Yagi, K.3
-
68
-
-
20844456215
-
Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients
-
K.K. Koh, M.J. Quon, and S.H. Han Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients Circulation 110 2004 3687 3692
-
(2004)
Circulation
, vol.110
, pp. 3687-3692
-
-
Koh, K.K.1
Quon, M.J.2
Han, S.H.3
-
69
-
-
33947304608
-
Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in non-diabetic patients at cardiovascular risk - The PIOSTAT Study
-
T. Forst, A. Pfutzner, and G. Lubben Effect of simvastatin and/or pioglitazone on insulin resistance, insulin secretion, adiponectin, and proinsulin levels in non-diabetic patients at cardiovascular risk - the PIOSTAT Study Metabolism 56 2007 491 496
-
(2007)
Metabolism
, vol.56
, pp. 491-496
-
-
Forst, T.1
Pfutzner, A.2
Lubben, G.3
-
70
-
-
48649083592
-
Simvastatin improves flowmediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients
-
K.K. Koh, M.J. Quon, and S.H. Han Simvastatin improves flowmediated dilation but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients Diabetes Care 31 2008 776 782
-
(2008)
Diabetes Care
, vol.31
, pp. 776-782
-
-
Koh, K.K.1
Quon, M.J.2
Han, S.H.3
-
71
-
-
35348874956
-
Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome
-
S. Devaraj, D. Siegel, and I. Jialal Simvastatin (40 mg/day), adiponectin levels, and insulin sensitivity in subjects with the metabolic syndrome Am J Cardiol 100 2007 1397 1399
-
(2007)
Am J Cardiol
, vol.100
, pp. 1397-1399
-
-
Devaraj, S.1
Siegel, D.2
Jialal, I.3
-
72
-
-
69349102944
-
Antiatherosclerotic and anti-insulin resistance effects of adiponectin: Basic and clinical studies
-
S.H. Han, I. Sakuma, and E.K. Shin Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies Prog Cardiovasc Dis 52 2009 126 140
-
(2009)
Prog Cardiovasc Dis
, vol.52
, pp. 126-140
-
-
Han, S.H.1
Sakuma, I.2
Shin, E.K.3
-
73
-
-
0242581695
-
Adiponectin stimulates production of nitric oxide in vascular endothelial cells
-
H. Chen, M. Montagnani, and T. Funahashi Adiponectin stimulates production of nitric oxide in vascular endothelial cells J Biol Chem 278 2003 45021 45026
-
(2003)
J Biol Chem
, vol.278
, pp. 45021-45026
-
-
Chen, H.1
Montagnani, M.2
Funahashi, T.3
-
74
-
-
10744223954
-
Association of hypoadiponectinemia with impaired vasoreactivity
-
N. Ouchi, M. Ohishi, and S. Kihara Association of hypoadiponectinemia with impaired vasoreactivity Hypertension 42 2003 231 234
-
(2003)
Hypertension
, vol.42
, pp. 231-234
-
-
Ouchi, N.1
Ohishi, M.2
Kihara, S.3
-
75
-
-
0037129861
-
Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell
-
Y. Arita, S. Kihara, and N. Ouchi Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell Circulation 105 2002 2893 2898
-
(2002)
Circulation
, vol.105
, pp. 2893-2898
-
-
Arita, Y.1
Kihara, S.2
Ouchi, N.3
-
76
-
-
24044538551
-
Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner
-
Y. Wang, K.S. Lam, and J.Y. Xu Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner J Biol Chem 280 2005 18341 18347
-
(2005)
J Biol Chem
, vol.280
, pp. 18341-18347
-
-
Wang, Y.1
Lam, K.S.2
Xu, J.Y.3
-
77
-
-
0034641647
-
Adiponectin, adipocyte-derived protein, inhibits endothelial NFkB signaling through cAMP-dependent pathway
-
N. Ouchi, S. Kihara, and Y. Arita Adiponectin, adipocyte-derived protein, inhibits endothelial NFkB signaling through cAMP-dependent pathway Circulation 102 2000 1296 1301
-
(2000)
Circulation
, vol.102
, pp. 1296-1301
-
-
Ouchi, N.1
Kihara, S.2
Arita, Y.3
-
78
-
-
0033613545
-
Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein
-
N. Ouchi, S. Kihara, and Y. Arita Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein Circulation 100 1999 2473 2476
-
(1999)
Circulation
, vol.100
, pp. 2473-2476
-
-
Ouchi, N.1
Kihara, S.2
Arita, Y.3
-
79
-
-
34249720420
-
Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver
-
F. Matsuura, H. Oku, and M. Koseki Adiponectin accelerates reverse cholesterol transport by increasing high density lipoprotein assembly in the liver Biochem Biophys Res Commun 358 2007 1091 1095
-
(2007)
Biochem Biophys Res Commun
, vol.358
, pp. 1091-1095
-
-
Matsuura, F.1
Oku, H.2
Koseki, M.3
-
80
-
-
50849100403
-
Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages
-
K. Tsubakio-Yamamoto, F. Matsuura, and M. Koseki Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages Biochem Biophys Res Commun 375 2008 390 394
-
(2008)
Biochem Biophys Res Commun
, vol.375
, pp. 390-394
-
-
Tsubakio-Yamamoto, K.1
Matsuura, F.2
Koseki, M.3
-
81
-
-
46249092855
-
Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells; Evidence for an adipose tissue-vascular loop
-
S. Devaraj, N. Torok, and R. Mohan Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells; evidence for an adipose tissue-vascular loop Arterioscler Thromb Vasc Biol 28 2008 1368 1374
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 1368-1374
-
-
Devaraj, S.1
Torok, N.2
Mohan, R.3
-
82
-
-
0035957040
-
Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages
-
N. Ouchi, S. Kihara, and Y. Arita Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation 103 2001 1057 1063
-
(2001)
Circulation
, vol.103
, pp. 1057-1063
-
-
Ouchi, N.1
Kihara, S.2
Arita, Y.3
-
83
-
-
50949114724
-
Reversal of oxidative stress in endothelial cells by controlled release of adiponectin
-
M. Mossalam, J.H. Jeong, and E.D. Abel Reversal of oxidative stress in endothelial cells by controlled release of adiponectin J Control Release 130 2008 234 237
-
(2008)
J Control Release
, vol.130
, pp. 234-237
-
-
Mossalam, M.1
Jeong, J.H.2
Abel, E.D.3
-
84
-
-
19444375353
-
Effects of adipocyte-derived cytokines on endothelial functions: Implication of vascular disease
-
P. Kougias, H. Chai, and P.H. Lin Effects of adipocyte-derived cytokines on endothelial functions: implication of vascular disease J Surg Res 126 2005 121 129
-
(2005)
J Surg Res
, vol.126
, pp. 121-129
-
-
Kougias, P.1
Chai, H.2
Lin, P.H.3
-
86
-
-
77951709095
-
Pleiotropic effects of statins. Basic research and clinical perspectives
-
Q. Zhou, and J.K. Liao Pleiotropic effects of statins. Basic research and clinical perspectives Circ J 74 2010 818 826
-
(2010)
Circ J
, vol.74
, pp. 818-826
-
-
Zhou, Q.1
Liao, J.K.2
-
88
-
-
10644259543
-
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): A multicentre randomized controlled trial
-
P.S. Sever, B. Dahlof, and N.R. Poulter Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial Drugs 64 2004 S43 S60
-
(2004)
Drugs
, vol.64
-
-
Sever, P.S.1
Dahlof, B.2
Poulter, N.R.3
-
89
-
-
0027987849
-
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
-
Simvastatin Survival Study Group
-
Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
-
(1994)
Lancet
, vol.344
, pp. 1383-1389
-
-
-
90
-
-
0342981862
-
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators
-
F.M. Sacks, M.A. Pfeffer, and L.A. Moye The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators N Engl J Med 335 1996 1001 1009
-
(1996)
N Engl J Med
, vol.335
, pp. 1001-1009
-
-
Sacks, F.M.1
Pfeffer, M.A.2
Moye, L.A.3
-
91
-
-
0032487931
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
-
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group N Engl J Med 339 1998 1349 1357
-
(1998)
N Engl J Med
, vol.339
, pp. 1349-1357
-
-
-
92
-
-
0037031061
-
MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
-
Protection Study Collaborative Group
-
Heart Protection Study Collaborative Group MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
93
-
-
0032572086
-
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study
-
J.R. Downs, M. Clearfield, and S. Weis Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study JAMA 279 1998 1615 1622
-
(1998)
JAMA
, vol.279
, pp. 1615-1622
-
-
Downs, J.R.1
Clearfield, M.2
Weis, S.3
-
94
-
-
0028883828
-
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group
-
J. Shepherd, S.M. Cobbe, and I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 333 1995 1301 1307
-
(1995)
N Engl J Med
, vol.333
, pp. 1301-1307
-
-
Shepherd, J.1
Cobbe, S.M.2
Ford, I.3
-
95
-
-
79956370935
-
Pleiotropic effects of statins: Evidence against benefits beyond LDL-cholesterol lowering
-
T.R. Pedersen Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering Am J Cardiovasc Drugs 10 2010 S10 S17
-
(2010)
Am J Cardiovasc Drugs
, vol.10
-
-
Pedersen, T.R.1
-
96
-
-
80052048877
-
Non-invited review: Prevention of microvascular diabetic complications by fenofibrate: Lessons from FIELD and ACCORD
-
M.P. Hermans Non-invited review: prevention of microvascular diabetic complications by fenofibrate: lessons from FIELD and ACCORD Diab Vasc Dis Res 8 2011 180 189
-
(2011)
Diab Vasc Dis Res
, vol.8
, pp. 180-189
-
-
Hermans, M.P.1
|